메뉴 건너뛰기




Volumn 16, Issue 4, 2005, Pages 281-286

Homozygous factor V Leiden mutation in two siblings presenting with acute myocardial infarction: A rare cause of myocardial infarction in the young

Author keywords

Acute myocardial infarction; Factor V Leiden mutation; Inherited thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CLOPIDOGREL; LISINOPRIL; METOPROLOL; STREPTOKINASE;

EID: 18944383209     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000169221.38797.9c     Document Type: Article
Times cited : (8)

References (36)
  • 1
  • 2
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
    • Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85:1504-1508.
    • (1995) Blood , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3    Reitsma, P.H.4
  • 3
    • 0028098210 scopus 로고
    • Resistance to activated protein C as a basis for venous thrombosis
    • Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330:517-522.
    • (1994) N Engl J Med , vol.330 , pp. 517-5522
    • Svensson, P.J.1    Dahlback, B.2
  • 4
    • 0028910906 scopus 로고
    • Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
    • Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332:912-917.
    • (1995) N Engl J Med , vol.332 , pp. 912-917
    • Ridker, P.M.1    Hennekens, C.H.2    Lindpaintner, K.3    Stampfer, M.J.4    Eisenberg, P.R.5    Miletich, J.P.6
  • 5
    • 18944407386 scopus 로고    scopus 로고
    • Factor V Leiden mutation is not a risk factor for myocardial infarction in north-east Turkey
    • Çelik S, Uçar F, Baykan M. Factor V Leiden mutation is not a risk factor for myocardial infarction in north-east Turkey. T Klin J Cardiol 2001; 14:104-106.
    • (2001) T Klin J Cardiol , vol.14 , pp. 104-106
    • Çelik, S.1    Uçar, F.2    Baykan, M.3
  • 6
    • 0033557905 scopus 로고    scopus 로고
    • Factor V Leiden is not a risk factor for myocardial infarction among young women
    • Amowitz LL, Komaroff AL, Miletich JP, Ridker PM. Factor V Leiden is not a risk factor for myocardial infarction among young women. Blood 1999; 93:1432-1433.
    • (1999) Blood , vol.93 , pp. 1432-1433
    • Amowitz, L.L.1    Komaroff, A.L.2    Miletich, J.P.3    Ridker, P.M.4
  • 8
    • 0028951045 scopus 로고
    • Premature ischaemic heart disease and the gene for coagulation factor V
    • Van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V [Letter]. Nat Med 1995; 1:185.
    • (1995) Nat Med , vol.1 , pp. 185
    • Van Bockxmeer, F.M.1    Baker, R.I.2    Taylor, R.R.3
  • 9
    • 0033121115 scopus 로고    scopus 로고
    • Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males
    • Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, et al. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999; 33:2186-2190.
    • (1999) Blood , vol.33 , pp. 2186-2190
    • Inbal, A.1    Freimark, D.2    Modan, B.3    Chetrit, A.4    Matetzky, S.5    Rosenberg, N.6
  • 10
    • 0028806737 scopus 로고
    • Evidence against heterozygous coagulation factor V 1619 G → A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction
    • Prohaska W, Mannebach H, Schmidt M, Gleichmann U, Kleesiek K. Evidence against heterozygous coagulation factor V 1619 G → A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction. J Mol Med 1995; 73:521-524.
    • (1995) J Mol Med , vol.73 , pp. 521-524
    • Prohaska, W.1    Mannebach, H.2    Schmidt, M.3    Gleichmann, U.4    Kleesiek, K.5
  • 11
    • 3442901367 scopus 로고    scopus 로고
    • Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction
    • Donmez Y, Kanadasi M, Tanriverdi K, Demir M, Demirtas M, Cayli M, et al. Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 2004; 45:505-512.
    • (2004) Jpn Heart J , vol.45 , pp. 505-512
    • Donmez, Y.1    Kanadasi, M.2    Tanriverdi, K.3    Demir, M.4    Demirtas, M.5    Cayli, M.6
  • 13
    • 0033537469 scopus 로고    scopus 로고
    • Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease
    • Kiechl S, Muigg A, Santer P, Mitterer M, Egger G, Oberhollenzer M, et al. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation 1999; 99:614-619.
    • (1999) Circulation , vol.99 , pp. 614-619
    • Kiechl, S.1    Muigg, A.2    Santer, P.3    Mitterer, M.4    Egger, G.5    Oberhollenzer, M.6
  • 14
    • 0028902044 scopus 로고
    • Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease
    • März W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease. Lancet 1995; 345:526-527.
    • (1995) Lancet , vol.345 , pp. 526-527
    • März, W.1    Seydewitz, H.2    Winkelmann, B.3    Chen, M.4    Nauck, M.5    Witt, I.6
  • 15
    • 3042811442 scopus 로고    scopus 로고
    • Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction
    • Middendorf K, Göhring P, Huehns TY, Seidel D, Steinbeck G, Nikol S. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction. Am Heart J 2004; 147: 897-904.
    • (2004) Am Heart J , vol.147 , pp. 897-904
    • Middendorf, K.1    Göhring, P.2    Huehns, T.Y.3    Seidel, D.4    Steinbeck, G.5    Nikol, S.6
  • 16
    • 0030984288 scopus 로고    scopus 로고
    • Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
    • Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89:2817-2821.
    • (1997) Blood , vol.89 , pp. 2817-2821
    • Rosendaal, F.R.1    Siscovick, D.S.2    Schwartz, S.M.3    Beverly, R.K.4    Psaty, B.M.5    Longstreth Jr., W.T.6
  • 17
    • 0032562254 scopus 로고    scopus 로고
    • Interaction of coagulation defects and cardiovascular risk factors increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A
    • Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 87:1037-1041.
    • (1998) Circulation , vol.87 , pp. 1037-1041
    • Doggen, C.J.1    Cats, V.M.2    Bertina, R.M.3    Rosendaal, F.R.4
  • 19
    • 0028810738 scopus 로고
    • World distribution of factor V Leiden
    • Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
    • (1995) Lancet , vol.346 , pp. 1133-1134
    • Rees, D.C.1    Cox, M.2    Clegg, J.B.3
  • 20
    • 0030955080 scopus 로고    scopus 로고
    • Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening
    • Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
    • (1997) JAMA , vol.277 , pp. 1305-1307
    • Ridker, P.M.1    Miletich, J.P.2    Hennekens, C.H.3    Buring, J.E.4
  • 21
    • 0031181982 scopus 로고    scopus 로고
    • The prevalence of factor V Leiden (1691 G → A) mutation in Turkey
    • Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G → A) mutation in Turkey. Turk J Pediatr 1997; 39:313-315.
    • (1997) Turk J Pediatr , vol.39 , pp. 313-315
    • Gurgey, A.1    Mesci, L.2
  • 22
    • 0036981213 scopus 로고    scopus 로고
    • Prothrombotic determinants of coronary atherothrombosis
    • Ruberg FL, Loscalzo J. Prothrombotic determinants of coronary atherothrombosis. Vasc Med 2002; 7:289-299.
    • (2002) Vasc Med , vol.7 , pp. 289-299
    • Ruberg, F.L.1    Loscalzo, J.2
  • 23
    • 0038683224 scopus 로고    scopus 로고
    • Prothrombotic and antithrombotic pathways in acute coronary syndromes
    • Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol 2003; 91:3H-11H.
    • (2003) Am J Cardiol , vol.91
    • Selwyn, A.P.1
  • 24
    • 0037219632 scopus 로고    scopus 로고
    • Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction
    • French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, et al. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. Am Heart J 2003; 145:118-124.
    • (2003) Am Heart J , vol.145 , pp. 118-124
    • French, J.K.1    Van De Water, N.S.2    Sutton, T.M.3    Lund, M.4    Gao, W.5    McDowell, J.6
  • 25
    • 0033852836 scopus 로고    scopus 로고
    • Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
    • Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ. Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol 2000; 36:717-722.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 717-722
    • Van De Water, N.S.1    French, J.K.2    Lund, M.3    Hyde, T.A.4    White, H.D.5    Browett, P.J.6
  • 26
    • 23444436924 scopus 로고
    • Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C
    • Lindblad B, Svensson PJ, Dahlback B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C [Letter]. Lancet 1994; 343:917.
    • (1994) Lancet , vol.343 , pp. 917
    • Lindblad, B.1    Svensson, P.J.2    Dahlback, B.3
  • 27
    • 0028110974 scopus 로고
    • Myocardial infarction associated with homozygous resistance to activated protein C
    • Holm J, Zöller B, Svensson PJ, Berntorp E, Erhardt L, Dahlbäck B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344:952-953.
    • (1994) Lancet , vol.344 , pp. 952-953
    • Holm, J.1    Zöller, B.2    Svensson, P.J.3    Berntorp, E.4    Erhardt, L.5    Dahlbäck, B.6
  • 28
    • 1342311289 scopus 로고    scopus 로고
    • Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia
    • Dropinski J, Wegrzyn W, Szczeklik W, Krzanowski M. Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia. Pol Arch Med Wewn 2004; 111:63-67.
    • (2004) Pol Arch Med Wewn , vol.111 , pp. 63-67
    • Dropinski, J.1    Wegrzyn, W.2    Szczeklik, W.3    Krzanowski, M.4
  • 29
    • 0035827416 scopus 로고    scopus 로고
    • Homozygous form of factor V Leiden mutation as the cause of a myocardial infarction in patient with an unremarkable coronary vascular system?
    • Menge H, Faig HG, Lang A, Fahrenkrog U, Lollgen H. Homozygous form of factor V Leiden mutation as the cause of a myocardial infarction in patient with an unremarkable coronary vascular system? Dtsch Med Wochenschr 2001; 123:684-686.
    • (2001) Dtsch Med Wochenschr , vol.123 , pp. 684-686
    • Menge, H.1    Faig, H.G.2    Lang, A.3    Fahrenkrog, U.4    Lollgen, H.5
  • 30
    • 1542287360 scopus 로고    scopus 로고
    • Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman
    • Agostoni P, Gasparini G, Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart 2004; 90:e12.
    • (2004) Heart , vol.90
    • Agostoni, P.1    Gasparini, G.2    Destro, G.3
  • 32
    • 18944369845 scopus 로고    scopus 로고
    • Activated protein C resistance and low molecular weight lipoprotein (a): Dual pathogens, for atherothrombosis?
    • in press
    • Anand S, Kliber A, Koschinsky ML. Activated protein C resistance and low molecular weight lipoprotein (a): dual pathogens, for atherothrombosis? Thrombosis Res 2004; in press.
    • (2004) Thrombosis Res
    • Anand, S.1    Kliber, A.2    Koschinsky, M.L.3
  • 33
    • 0032569645 scopus 로고    scopus 로고
    • Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease
    • Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998; 158:2101-2106.
    • (1998) Arch Intern Med , vol.158 , pp. 2101-2106
    • Ray, J.G.1
  • 34
    • 0026034240 scopus 로고
    • Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease
    • Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48:536-545.
    • (1991) Am J Hum Genet , vol.48 , pp. 536-545
    • Kang, S.-S.1    Wong, P.W.K.2    Susmano, A.3    Sora, J.4    Norusis, M.5    Ruggie, N.6
  • 35
    • 0029049553 scopus 로고
    • A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
    • Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:110-113.
    • (1995) Nat Genet , vol.10 , pp. 110-113
    • Frosst, P.1    Blom, H.J.2    Milos, R.3    Goyette, P.4    Sheppard, C.A.5    Matthews, R.G.6
  • 36
    • 0031464710 scopus 로고    scopus 로고
    • Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C
    • Glueck CJ, Fontaine RN, Gupta A, Alasmi M. Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C. Metabolism 1997; 46:1470-1472.
    • (1997) Metabolism , vol.46 , pp. 1470-1472
    • Glueck, C.J.1    Fontaine, R.N.2    Gupta, A.3    Alasmi, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.